Encapsulated ATRA in pegylated liposomes was shown to accumulate inside tumours resulting in increased delivery and duration of ATRA capable of inhibiting MDSC and synergizing with anti-PD-1 treatment to result in increased CD8 T-cell infiltration [235]. Here, PDCD1 is linked to neoplasm.